Safety and efficacy of amniotic cytokine extract in the treatment of dry eye disease
Elizabeth Yeu,1 Damien F Goldberg,2 Francis S Mah,3 Kenneth A Beckman,4,5 Jodi I Luchs,6,7 Jonathan D Solomon,8 Darrell E White,9 Preeya K Gupta101Eastern Virginia Medical School, Virginia Eye Consultants, Norfolk, VA, USA; 2Wolstan & Goldberg Eye Associates, Torrance, CA, USA; 3Scripps Clin...
Guardado en:
Autores principales: | Yeu E, Goldberg DF, Mah FS, Beckman KA, Luchs JI, Solomon JD, White DE, Gupta PK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a333de8516834ac48e82963aa8ad8872 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Amniotic Membrane Transplantation in Ophthalmology: An Updated Perspective
por: Walkden A
Publicado: (2020) -
Amniotic membrane extract and eye drops: a review of literature and clinical application
por: Murri MS, et al.
Publicado: (2018) -
Treatment outcomes in the DRy Eye Amniotic Membrane (DREAM) study
por: McDonald MB, et al.
Publicado: (2018) -
Management of Persistent Corneal Epithelial Defects with Human Amniotic Membrane-derived Dry Matrix
por: Maqsood S, et al.
Publicado: (2021) -
Making the diagnosis of Sjögren’s syndrome in patients with dry eye
por: Beckman KA, et al.
Publicado: (2015)